CryoPort (CYRX) Competitors $8.77 +0.13 (+1.50%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$8.78 +0.01 (+0.06%) As of 09/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. HRMY, ANIP, ARQT, DYN, RXRX, ADPT, TVTX, IMCR, MESO, and SRPTShould you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Harmony Biosciences (HRMY), ANI Pharmaceuticals (ANIP), Arcutis Biotherapeutics (ARQT), Dyne Therapeutics (DYN), Recursion Pharmaceuticals (RXRX), Adaptive Biotechnologies (ADPT), Travere Therapeutics (TVTX), Immunocore (IMCR), Mesoblast (MESO), and Sarepta Therapeutics (SRPT). These companies are all part of the "pharmaceutical products" industry. CryoPort vs. Its Competitors Harmony Biosciences ANI Pharmaceuticals Arcutis Biotherapeutics Dyne Therapeutics Recursion Pharmaceuticals Adaptive Biotechnologies Travere Therapeutics Immunocore Mesoblast Sarepta Therapeutics Harmony Biosciences (NASDAQ:HRMY) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings. Which has higher valuation & earnings, HRMY or CYRX? Harmony Biosciences has higher revenue and earnings than CryoPort. CryoPort is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarmony Biosciences$714.73M2.62$145.49M$3.1010.48CryoPort$228.38M1.92-$114.76M$1.336.59 Which has more volatility and risk, HRMY or CYRX? Harmony Biosciences has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500. Does the media refer more to HRMY or CYRX? In the previous week, Harmony Biosciences had 1 more articles in the media than CryoPort. MarketBeat recorded 9 mentions for Harmony Biosciences and 8 mentions for CryoPort. Harmony Biosciences' average media sentiment score of 1.50 beat CryoPort's score of 1.31 indicating that Harmony Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harmony Biosciences 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CryoPort 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HRMY or CYRX? Harmony Biosciences currently has a consensus target price of $51.00, indicating a potential upside of 56.92%. CryoPort has a consensus target price of $12.00, indicating a potential upside of 36.83%. Given Harmony Biosciences' higher probable upside, equities research analysts clearly believe Harmony Biosciences is more favorable than CryoPort.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harmony Biosciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00CryoPort 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in HRMY or CYRX? 86.2% of Harmony Biosciences shares are held by institutional investors. Comparatively, 92.9% of CryoPort shares are held by institutional investors. 23.6% of Harmony Biosciences shares are held by insiders. Comparatively, 10.1% of CryoPort shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is HRMY or CYRX more profitable? CryoPort has a net margin of 37.21% compared to Harmony Biosciences' net margin of 23.44%. Harmony Biosciences' return on equity of 26.34% beat CryoPort's return on equity.Company Net Margins Return on Equity Return on Assets Harmony Biosciences23.44% 26.34% 17.71% CryoPort 37.21%-9.79%-5.42% SummaryHarmony Biosciences beats CryoPort on 11 of the 14 factors compared between the two stocks. Get CryoPort News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoPortTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$432.58M$5.82B$7.14B$10.18BDividend YieldN/A2.32%940.04%4.61%P/E Ratio6.5910.9313.7726.39Price / Sales1.921.22460.83125.97Price / CashN/A11.137.9829.91Price / Book1.183.022.206.28Net Income-$114.76M$184.49M$556.72M$270.38M7 Day Performance-10.96%2.36%1.33%1.89%1 Month Performance1.86%3.29%3.11%6.01%1 Year Performance5.79%-3.35%9.51%25.26% CryoPort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoPort3.9907 of 5 stars$8.77+1.5%$12.00+36.8%+5.0%$432.58M$228.38M6.591,186Positive NewsInsider TradeHRMYHarmony Biosciences4.5986 of 5 stars$35.83-0.4%$51.00+42.3%-16.5%$2.07B$714.73M11.56200Positive NewsHigh Trading VolumeANIPANI Pharmaceuticals3.9283 of 5 stars$95.20-0.2%$88.25-7.3%+68.9%$2.07B$614.38M-123.63600ARQTArcutis Biotherapeutics2.35 of 5 stars$17.33+1.0%$19.80+14.3%+58.8%$2.06B$196.54M-23.11150DYNDyne Therapeutics3.9294 of 5 stars$13.30-6.5%$34.07+156.1%-62.2%$2.02BN/A-3.45100Positive NewsRXRXRecursion Pharmaceuticals2.1483 of 5 stars$4.62+0.2%$7.25+56.9%-27.4%$2.00B$58.84M-2.60400Gap UpADPTAdaptive Biotechnologies3.5292 of 5 stars$12.54-2.4%$12.38-1.3%+183.7%$1.96B$178.96M-15.29790Positive NewsTVTXTravere Therapeutics2.9713 of 5 stars$21.20-2.0%$33.43+57.7%+70.7%$1.93B$233.18M-10.39460Analyst ForecastGap UpIMCRImmunocore1.8602 of 5 stars$36.64-1.5%$56.89+55.3%+2.6%$1.87B$310.20M-91.60320News CoverageMESOMesoblast1.8335 of 5 stars$14.55+1.1%$18.00+23.7%+148.6%$1.84B$17.20M0.0080News CoveragePositive NewsGap UpSRPTSarepta Therapeutics4.4228 of 5 stars$17.60-5.9%$43.50+147.2%-86.0%$1.83B$1.90B-20.231,372Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Harmony Biosciences Competitors ANI Pharmaceuticals Competitors Arcutis Biotherapeutics Competitors Dyne Therapeutics Competitors Recursion Pharmaceuticals Competitors Adaptive Biotechnologies Competitors Travere Therapeutics Competitors Immunocore Competitors Mesoblast Competitors Sarepta Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredThe End of Elon Musk…?Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoPort, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoPort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYRX Stock Alerts